Sanford C. Bernstein
https://www.bernsteinresearch.comSanford C. Bernstein, a division of AllianceBernstein, is a research firm.
View Older Stories View More Recent Stories
-
Gordon Haskett Sees PayPal (PYPL) As Fitting Pershing Square's Investment Thesis
-
GRIN, the World’s Leading Creator Management Platform, Announces Former Hootsuite Executive as CPTO
-
Minerva Surgical (UTRS) Appoints Derrick Sung to its Board
-
Minerva Surgical Announces Appointment of Derrick Sung, Ph.D. to Board of Directors
-
ModuleQ Welcomes London Stock Exchange Group's Kristen Brearey to Board of Directors
-
Explainer-Ukraine pushes for debt freeze to dodge hard default
-
The Hartford Declares Quarterly Dividends Of $0.385 Per Share Of Common Stock And $375 Per Share Of Series G Preferred Stock
-
Alibaba (BABA) Upgraded By Bernstein on Attractive Risk-Reward
-
T-Mobile Gives Customers ViX+ on Us
-
Datadog Pops as Bernstein Starts at Outperform, Top Pick in US SMID Software
-
NEW AI PLATFORM FOR NONPROFITS TO IMPROVE FUNDRAISING RAISES $1.5M IN PRE-SEED FUNDING
-
UPDATE: Bernstein Starts Datadog (DDOG) at Outperform, Top Pick
-
UPDATE: Bernstein Starts Zoom Video (ZM) at Market Perform
-
UPDATE: Bernstein Starts Okta, Inc (OKTA) at Market Perform
-
Bernstein Starts Twilio (TWLO) at Market Perform
-
UPDATE: Bernstein Starts Atlassian Corporation (TEAM) at Outperform
-
UPDATE: Bernstein Upgrades Alibaba (BABA) to Outperform
-
UPDATE: Bernstein Downgrades Cummins (CMI) to Market Perform
-
Analysis - Porsche faces uphill drive in race to public listing
-
UPDATE: Bernstein Starts Aston Martin Lagonda Global Holdings Plc. (AML:LN) (ARGGY) at Market Perform
-
UPDATE: Bernstein Starts Ferrari NV (RACE:IM) (RACE) at Market Perform
-
Apple: Bernstein's Sacconaghi Sees FQ3 Beat but 2023 Estimates Likely 'Too High'
-
AB to Report Second Quarter 2022 Results on July 29, 2022
-
Bernstein Starts DexCom (DXCM) at Outperform
-
If you purchased Theranos blood testing services, including at a Walgreens store, a class action lawsuit may affect your rights
-
Swatch Group upbeat as China comes out of lockdown
-
New Federal Guidance Confuses an Already Complicated Landscape for Pharmacists
-
Frequency Electronics, Inc. Announces Year End Fiscal Year 2022 Financial Results
-
Frequency Electronics, Inc. Announces Year End Fiscal Year 2022 Financial Results
-
Frequency Electronics, Inc., Announces Thomas McClelland as Interim CEO, Replacing Stanton Sloane Who Has Retired
-
Frequency Electronics, Inc., Announces Thomas McClelland as Interim CEO, Replacing Stanton Sloane Who Has Retired
-
Balto CEO Marc Bernstein Wins CCW Next Generation Leaders Award
-
If you were affected by the 2015 Santa Barbara Oil Spill, you may be entitled to a payment from a class action settlement
-
Computer chips face toilet paper hoarding moment as shortage turns to glut
-
Form 4 SYNCHRONOSS TECHNOLOGIES For: Jul 08 Filed by: Bernstein Martin Francis
-
Frequency Electronics, Inc. Announces Year End Fiscal 2022 Financial Results Conference Call: Wednesday, July 13, 2022, at 4:30 PM ET
-
Frequency Electronics, Inc. Announces Year End Fiscal 2022 Financial Results Conference Call: Wednesday, July 13, 2022, at 4:30 PM ET
-
Lieff Cabraser Announces Mark Chalos Named President of the Tennessee Trial Lawyers Association
-
Bernstein Says Macau Lockdown May Last Longer than 7 days, Reduces GGR Forecast
-
Rushnet, Inc. and heliosDX Launch AutoUA(R) Testing to Enhance Patient Care and Help Prevent Kidney Disease Among Other Conditions including UTI
-
Finalists Announced for the 16th Annual Invest in Others Awards
-
Aquestive Therapeutics Reports Positive Results from Final Two Arms of EPIPHAST Trial Supporting Performance and Real-World Functionality of AQST-109 Epinephrine Oral Film
-
Aquestive Therapeutics Reports Positive Results from Final Two Arms of EPIPHAST Trial Supporting Performance and Real-World Functionality of AQST-109 Epinephrine Oral Film
-
Some U.S. students re-think college plans in states with abortion bans
-
Summary Notice of Proposed Class Action Settlement Involving BofI Holding, Inc. Common Stock, Call Options and Put Options
-
U.S. mulls fresh bid to restrict chipmaking tools for China's SMIC -sources
-
German investor Kuehne boosts stake in Lufthansa to 15%
-
Breaking: FDA permits pharmacists to prescribe Paxlovid to treat COVID-19
-
Form 4 CMC Materials, Inc. For: Jul 06 Filed by: ECKSTEIN BERNSTEIN H CAROL
-
Bernstein Reiterates Outperform on Uber, Says Shares Could Rally Over 60%

